JP2022519820A - 光照射装置 - Google Patents
光照射装置 Download PDFInfo
- Publication number
- JP2022519820A JP2022519820A JP2021543131A JP2021543131A JP2022519820A JP 2022519820 A JP2022519820 A JP 2022519820A JP 2021543131 A JP2021543131 A JP 2021543131A JP 2021543131 A JP2021543131 A JP 2021543131A JP 2022519820 A JP2022519820 A JP 2022519820A
- Authority
- JP
- Japan
- Prior art keywords
- light
- irradiated
- irradiation device
- light source
- wavelength band
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000758 substrate Substances 0.000 claims abstract description 27
- 206010052428 Wound Diseases 0.000 claims description 41
- 208000027418 Wounds and injury Diseases 0.000 claims description 41
- 230000001678 irradiating effect Effects 0.000 claims description 32
- 230000001154 acute effect Effects 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 238000010586 diagram Methods 0.000 abstract description 34
- 241000894006 Bacteria Species 0.000 description 86
- 230000000844 anti-bacterial effect Effects 0.000 description 62
- 230000001954 sterilising effect Effects 0.000 description 36
- 230000000052 comparative effect Effects 0.000 description 34
- 238000004659 sterilization and disinfection Methods 0.000 description 26
- 230000001580 bacterial effect Effects 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 20
- 238000001727 in vivo Methods 0.000 description 19
- 238000001228 spectrum Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 11
- 108091093078 Pyrimidine dimer Proteins 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 230000002354 daily effect Effects 0.000 description 9
- 206010041925 Staphylococcal infections Diseases 0.000 description 8
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- ASJWEHCPLGMOJE-LJMGSBPFSA-N ac1l3rvh Chemical compound N1C(=O)NC(=O)[C@@]2(C)[C@@]3(C)C(=O)NC(=O)N[C@H]3[C@H]21 ASJWEHCPLGMOJE-LJMGSBPFSA-N 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 150000004032 porphyrins Chemical class 0.000 description 6
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 5
- 230000009946 DNA mutation Effects 0.000 description 5
- 206010039509 Scab Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002991 immunohistochemical analysis Methods 0.000 description 2
- 230000004941 influx Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 230000001699 photocatalysis Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0047—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/084—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
[発明を実施するための形態]
Claims (20)
- ハウジングと、
前記ハウジング内に設けられた基板と、
前記基板上に実装された光源と、を含み、
前記光源は、
青色波長帯域の第1の光を出射する少なくとも1つの第1光源と、
紫外線波長帯域の第2の光を出射する少なくとも1つの第2光源と、
前記第1の光の出射と前記第2の光の出射とが重なるか否かにかかわらず、前記第1の光と前記第2の光とが順次又は近接したタイミングで出射されるように、前記第1光源及び前記第2光源の発光を制御する制御部と、を含み、
前記第2光源のドーズ量は前記第1光源のドーズ量の1/10以下である、光照射装置。 - 前記制御部は、前記第1の光の出射が開始された後、前記第2の光が出射されるように前記第1光源及び第2光源を制御する、請求項1に記載の光照射装置。
- 前記第2の光は、UVA、UVB、及びUVCの波長帯域のうち少なくとも一つの波長帯域に対応する、請求項1に記載の光照射装置。
- 前記第1の光は約400nm~約500nmの波長帯域を有する、請求項2に記載の光照射装置。
- 前記第1の光は、可視光に対応する波長帯域の光をさらに含む、請求項1に記載の光照射装置。
- 前記第1の光は約380nm~約780nmの波長帯域を有する、請求項5に記載の光照射装置。
- 前記第2の光は約240nm~約280nmの波長帯域を有する、請求項1に記載の光照射装置。
- 前記第1の光は第1の時間にわたって照射され、前記第2の光は、前記第1の時間より短い第2の時間にわたって照射される、請求項7に記載の光照射装置。
- 前記第2の光は、前記第1の光の照射が停止した後で照射が開始される、請求項8に記載の光照射装置。
- 前記第2の光は、前記第1の光の照射が停止する前に照射が開始され、前記第1の時間と前記第2の時間の少なくとも一部が互いに重畳する期間を有する、請求項8に記載の光照射装置。
- 前記第1の光は連続的に照射される、請求項8に記載の光照射装置。
- 前記第2の光は不連続的に照射される、請求項8に記載の光照射装置。
- 前記第2の光は周期的に照射される、請求項8に記載の光照射装置。
- 前記光照射装置は人体の治療に用いられる、請求項1に記載の光照射装置。
- 前記光照射装置は急性創傷の治療に用いられる、請求項14に記載の光照射装置。
- 前記第2光源は、1日当たり所定のドーズ量の範囲内で前記第2の光を照射し、前記1日当たり所定のドーズ量は、前記第2の光が人体に照射される際に無害な範囲内となる許容ドーズ量である、請求項1に記載の光照射装置。
- 前記第2の光は、約30J/m2~約1,000,000J/m2のドーズ量で照射される、請求項16に記載の光照射装置。
- 青色波長帯域の第1の光を出射する少なくとも1つの第1光源と、
紫外線波長帯域の第2の光を出射する少なくとも1つの第2光源と、
前記第1光源が前記第1の光を出射した後に、前記第2光源が前記第2の光を順次出射するように前記第1光源及び第2光源を制御する制御部と、を含み、
前記第2光源のドーズ量は、前記第1光源のドーズ量に対して1/10以下である、治療用光照射装置。 - 前記第1の光は約400nm~約500nmの波長帯域を有し、前記第2の光は約240nm~約280nmの波長帯域を有する、請求項18に記載の治療用光照射装置。
- 前記第1の光が第1の時間にわたって照射され、前記第2の光は、前記第1の時間より短い第2の時間にわたって照射される、請求項19に記載の治療用光照射装置。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962795730P | 2019-01-23 | 2019-01-23 | |
US62/795,730 | 2019-01-23 | ||
US201962825993P | 2019-03-29 | 2019-03-29 | |
US62/825,993 | 2019-03-29 | ||
US16/747,688 | 2020-01-21 | ||
US16/747,688 US20200230435A1 (en) | 2019-01-23 | 2020-01-21 | Light radiation device for medical treatment |
PCT/KR2020/001167 WO2020153788A1 (ko) | 2019-01-23 | 2020-01-23 | 광 조사 장치 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022519820A true JP2022519820A (ja) | 2022-03-25 |
JPWO2020153788A5 JPWO2020153788A5 (ja) | 2023-01-25 |
Family
ID=71609563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021543131A Pending JP2022519820A (ja) | 2019-01-23 | 2020-01-23 | 光照射装置 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20200230435A1 (ja) |
EP (1) | EP3915635A4 (ja) |
JP (1) | JP2022519820A (ja) |
KR (1) | KR20210107869A (ja) |
CN (1) | CN112512629A (ja) |
CA (1) | CA3127589A1 (ja) |
WO (1) | WO2020153788A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210322782A1 (en) * | 2020-04-16 | 2021-10-21 | Pathy Medical, Llc | Therapeutic lighting devices and methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960201B2 (en) * | 2002-02-11 | 2005-11-01 | Quanticum, Llc | Method for the prevention and treatment of skin and nail infections |
US8128672B2 (en) * | 2006-05-09 | 2012-03-06 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
US8109981B2 (en) * | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
US9463333B2 (en) * | 2007-07-05 | 2016-10-11 | Koninklijke Philips N.V. | Skin treatment device, lamp and use |
JP5534331B2 (ja) * | 2010-07-30 | 2014-06-25 | カシオ計算機株式会社 | 光源ユニット及びプロジェクタ |
US20160015962A1 (en) * | 2014-07-16 | 2016-01-21 | Mehdi Shokoueinejad Maragheh | Smart Patch For Wound Management |
KR101515992B1 (ko) * | 2015-02-09 | 2015-05-06 | (주)씨엘라이트 | 휴대용 피부 치료기기 |
KR20180067499A (ko) * | 2015-07-14 | 2018-06-20 | 비타빔 엘티디. | 위생, 소독 및 멸균을 위한 방법 및 장치 |
US20180093107A1 (en) * | 2016-09-30 | 2018-04-05 | Gliese 623B, LLC | System and Method For Healing and/or Disinfecting Wounds and Burns |
-
2020
- 2020-01-21 US US16/747,688 patent/US20200230435A1/en not_active Abandoned
- 2020-01-23 EP EP20744759.0A patent/EP3915635A4/en active Pending
- 2020-01-23 CA CA3127589A patent/CA3127589A1/en active Pending
- 2020-01-23 WO PCT/KR2020/001167 patent/WO2020153788A1/ko unknown
- 2020-01-23 CN CN202080004267.1A patent/CN112512629A/zh active Pending
- 2020-01-23 KR KR1020217025132A patent/KR20210107869A/ko unknown
- 2020-01-23 JP JP2021543131A patent/JP2022519820A/ja active Pending
-
2022
- 2022-10-13 US US17/965,087 patent/US20230045570A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20210107869A (ko) | 2021-09-01 |
CN112512629A (zh) | 2021-03-16 |
WO2020153788A1 (ko) | 2020-07-30 |
US20200230435A1 (en) | 2020-07-23 |
CA3127589A1 (en) | 2020-07-30 |
EP3915635A4 (en) | 2022-12-07 |
US20230045570A1 (en) | 2023-02-09 |
EP3915635A1 (en) | 2021-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111065363B (zh) | 医疗用敷料 | |
US20210268310A1 (en) | Apparatus, method, and system for selectively effecting and/or killing bacteria | |
Stein et al. | Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro | |
US7918229B2 (en) | Method and device to inactivate and kill cells and organisms that are undesirable | |
US10307495B2 (en) | Sterilizing apparatus | |
US20100222852A1 (en) | Apparatus and Method for Decolonizing Microbes on the Surfaces of the Skin and In Body Cavities | |
US7713294B2 (en) | Near infrared microbial elimination laser systems (NIMEL) | |
JP7472162B2 (ja) | 光照射装置 | |
US20050288746A1 (en) | Device for treating infants with light | |
WO2010029292A1 (en) | Irradiation apparatus and treatment | |
Enwemeka et al. | The role of UV and blue light in photo-eradication of microorganisms | |
Fornaini et al. | Use of blue and blue-violet lasers in dentistry: A narrative review | |
US20230045570A1 (en) | Light radiation device for medical treatment | |
WO2007123859A2 (en) | Method and device to inactivate and kill cells and organisms that are undesirable | |
Ribeiro et al. | Exploring light-based technology for wound healing and appliance disinfection | |
Hönes et al. | Visible optical radiation generates bactericidal effect applicable for inactivation of health care associated germs demonstrated by inactivation of E. coli and B. subtilis using 405 nm and 460 nm light emitting diodes | |
US20210346717A1 (en) | Rigel | |
WO2014177837A1 (en) | Photodynamic therapy | |
US20100143857A1 (en) | Photo-activated disinfection | |
US11931470B2 (en) | Visible light chromophore excitation for microorganism control | |
Fornaini et al. | Use of Blue and Blue-Violet Lasers in Dentistry: A Narrative Review: Blue-Violet Lasers in Dentistry | |
KR20140140385A (ko) | 치과용 유니트 살균기 | |
KR20070002795A (ko) | 광선치료기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230112 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230112 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231013 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231017 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240112 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240326 |